-
Abstract Number: PB1847
P-selectin (CD62P) Deficiency Is Associated with Increased Coxsackievirus B3 Myocarditis But Not Influenza A Virus Infection in Mice
-
Abstract Number: PB1725
P2Y12 Receptor Gene Polymorphisms and Platelet Aggregation at Patients with Arterial Hypertension in Bukovinian Region
-
Abstract Number: OC 14.2
PAD4-Dependent Assembly of NLRP3 Inflammasome Promotes NET Formation Resulting in Venous Thrombus Progression
-
Abstract Number: PB0536
Paediatric APTT, PT and Fibrinogen Reference Intervals Using STA® – CK Prest, STA® – NeoPTimal and STA® – Liquid Fib
-
Abstract Number: PB1009
Pain Status in Patients with Hemophilia: Evaluation of Routine Pain Assessment in an Unselected Cohort of Patients with Hemophilia A and B
-
Abstract Number: PB0478
Panel of Prothrombotic-inflammation Genetic Markers and Thrombin Generation Assay for Evaluation of Thromboprophilaxis and Thrombosis Risk in Thrombophilia Patients
-
Abstract Number: PB2029
PAR1-Derived and PAR3-Derived Peptides and their Variants Synergistically Inhibit Human Macrophage NLRP3-Dependent Inflammasome Activity
-
Abstract Number: PB0387
Paradoxical Platelet Inhibitory Effect of Protein C Deficiency in Shear-dependent Thrombus and Fibrin Formation
-
Abstract Number: PB2303
Particularities of Venous Thromboembolism in Systemic Vasculitides
-
Abstract Number: PB2216
Patency and Clinical Outcomes of Venous Recanalization in the Treatment of Postthrombotic Syndrome
-
Abstract Number: PB1321
Pathogenic Mechanisms Contributing to Thrombocytopenia in Patients with Systemic Lupus Erythematosus
-
Abstract Number: PB1231
Patient Compliance with Aspirin and Rivaroxaban Post Elective Joint Replacement Surgery: A Quality Assurance Initiative
-
Abstract Number: PB2164
Patients Experience of Living with Cancer Associated Thrombosis in Singapore (PELICAN)
-
Abstract Number: PB1875
Patients with Acute Thrombotic Thrombocytopenic Purpura (TTP) Should Be Managed in a Critical Care Setting – A UK Single TTP Referral Centre Experience
-
Abstract Number: PB1920
Patients with Antiphospholipid Syndrome Display a Marked Resistance to the Profibrinolytic Activity of Anticoagulants
-
Abstract Number: PB1372
Pattern of Central Nervous System Involvement an Emerging Allied Complications of Dengue Hemorrhagic Fever. A literature Review
-
Abstract Number: PB1690
PCSK9 in Human Platelets: Characterization and Mechanism of Platelet Activation
-
Abstract Number: PB0074
PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation
-
Abstract Number: PB2528
Peculiarities of the Hemostasis System in Pregnant Women with Severe Preeclampsia
-
Abstract Number: PB1264
Pediatric Heart Transplantation and Mechanical Circulatory Assistance: A Challenge for Hemostasis
-
Abstract Number: PB1267
Pediatric Hospital-Acquired Venous Thromboembolism: Mayo Eugenio Litta Children´s Hospital Experience
-
Abstract Number: PB1285
Pediatric Thrombosis: A Retrospective Analysis of the Incidence, Characteristics and Risk Factors in a Spanish Center
-
Abstract Number: PB1567
Pelvic Haematoma in Women with Bleeding Disorders: A Single Center Experience
-
Abstract Number: PB1921
Penile Mondor’s Disease Associated with Anticardiolipid Antibodies: A Very Rare Case of Antiphospholipid Syndrome
-
Abstract Number: PB0666
Performance Evaluation of a New Fibrinogen Assay Reagent Using Recombinant batroxobin
-
Abstract Number: PB1876
Performance Evaluation of a New Fully Automated Fluorogenic ADAMTS13 Activity Assay
-
Abstract Number: PB0530
Performance Evaluation of Anysis-200 Platelet Function Analyzer in Cardiology Patients
-
Abstract Number: PB0635
Performance Evaluation of Automated Thrombin Generation Measurement on Ceveron® t100 with Normalized TGA Parameters
-
Abstract Number: PB0728
Performance of a New Automated FXIII Activity Assay
-
Abstract Number: PB0648
Performance of the DP-Filter to Remove DOACs from Plasma. An Analytical Validation Demonstrating its Efficiency and Innocuity
-
Abstract Number: PB0592
Performance of Thrombin Generation Test (TGT) versus Conventional Coagulometric Methods in Snakebites: Preliminary Results
-
Abstract Number: PB0542
Performance of Thrombophilia Markers Assays Evaluated from Results of an External Quality Assessment Program
-
Abstract Number: PB1490
Periodic rFVIIa Prophylaxis due to Recurrent Haemarthroses into the Right Ankle Joint in a Patient with Glanzmann´s Thrombasthenia
-
Abstract Number: PB0221
Perioperative Management of Acquired Factor XI Deficiency: A Case Report and Review of Literature
-
Abstract Number: PB1142
Perioperative Management of Patients with Hemophilia Receiving Fitusiran, an Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia
-
Abstract Number: PB1193
Perioperative Management of Patients with Rare Bleeding Disorders in a Hemophilia Comprehensive Care Centre
-
Abstract Number: PB0983
Perioperative Management with Recombinant Factor IX Fc Fusion (rFIXFc): Irish and UK Experience
-
Abstract Number: PB2045
Persistence to Direct Oral Anticoagulants among Non-Valvular Atrial Fibrillation Patients in the Netherlands: A Nationwide Cohort Study
-
Abstract Number: PB2546
Personalized Control of Anticoagulant and Antiplatelet Therapy for Pregnant Women with a Complicated Obstetric Anamnesis Is Pathogenetically Justified for the Purpose of Prevention of Placenta-associated Complications
-
Abstract Number: PB1942
Personalized Dosing of Eculizumab Using C5 Functional Activity and Eculizumab Level in Complement-mediated Thrombotic Microangiopathy: A Safe and Cost-saving Approach
-
Abstract Number: PB0920
Personalizing Prophylaxis with Rurioctocog Alfa Pegol in Previously Treated Patients with Severe Hemophilia A: Outcomes from the Phase 3b CONTINUATION and Phase 3 PROPEL Studies
-
Abstract Number: PB0292
Pharmacodynamic Approach to Manage Patients on Direct Oral Anticoagulants Undergoing Elective Major Surgery and Operative Endoscopy
-
Abstract Number: PB1035
Pharmacokinetic and Clinical Improvements after PK-guided Switch from Standard Half-life to Extended Half-life Factor VIII Products
-
Abstract Number: PB1271
Pharmacokinetic Modelling and Simulation Support the Age and Body-Weight-Adjusted Dosing of Dabigatran Etexilate in Paediatric Patients with Venous Thromboembolism
-
Abstract Number: PB0901
Pharmacokinetic Profile of Southeastern Brazilian Hemophilia A Patients on Prophylaxis with Octocog Alfa
-
Abstract Number: PB1272
Pharmacokinetic-Pharmacodynamic Relationship between Dabigatran Plasma Concentrations and Coagulation Laboratory Parameters in Paediatric Patients with Venous Thromboembolism
-
Abstract Number: PB1350
Pharmacokinetic/Phamacodynamic (PK/PD) Modeling Providing Guidance for Selecting Avatrombopag (AVA) Dose when Switching from Eltrombopag in Chronic Immune Thrombocytopenia (ITP)
-
Abstract Number: PB0942
Pharmacokinetics and Coagulation Biomarkers in Persons with Hemophilia A (PwHA) and FVIII Inhibitors Receiving Emicizumab in the Phase IIIb STASEY Study
-
Abstract Number: PB0184
Pharmacopeial Potency Equated Sulodexide Produces Comparable Anticoagulation as Studied in Whole Blood
-
Abstract Number: PB0941
Phase 1 Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Ascending Doses of Subcutaneous Marzeptacog Alfa (Activated) in Adult Subjects with Hemophilia
-
Abstract Number: PB/LB05
Phase 2 Study of Efgartigimod, a Novel FcRn Antagonist, in Adult Patients with Primary Immune Thrombocytopenia
-
Abstract Number: OC 03.5
Phase I/II Trial of SPK-8011: Stable and Durable FVIII Expression for >2 Years with Significant ABR Improvements in Initial Dose Cohorts Following AAV-Mediated FVIII Gene Transfer for Hemophilia A
-
Abstract Number: PB1318
Phase I/II, Open-Label, Ongoing Study of PRN1008 (Rilzabrutinib), an Oral Bruton Tyrosine Kinase Inhibitor, in Patients with Heavily Pretreated Immune Thrombocytopenia (ITP)
-
Abstract Number: PB1443
Phenotype and Characteristics of a Cohort of Macrothrombocytopenic Patients Related to the AlphaIIbbêta3 Variants
-
Abstract Number: PB1718
Phosphoproteomic Fingerprint of Platelets in Obesity: Insights into Platelet Reactivity
-
Abstract Number: PB1750
Phosphorylation and Activation of Pannexin-1 upon Platelet Activation and Thrombus Formation
-
Abstract Number: PB2305
Photoshop-GSM versus Customized-GSM Software to Analysis of Echogenicity of Residual Venous Obstruction
-
Abstract Number: PB0989
Physical Activity, Sport and Haemophilia: An Observational Study on Risk Assessment
-
Abstract Number: PB0495
Physicochemical Changes by Missense Mutations Influences in Hemophilia A Determination
-
Abstract Number: PB1698
Physiological extracellular calcium levels impairs platelet aggregation as a result of iPLA2 inhibition due to lack of calcium stores´ depletion
-
Abstract Number: PB1740
Physiological Significance of Lysophosphatidylinositol/G Protein-coupled Receptor 55 System in the Regulation of Platelet Function
-
Abstract Number: PB0103
PI3KC2β Deficiency Stabilizes Adherens Junctions and Preserves Vascular Integrity in Stroke Models
-
Abstract Number: PB1043
Pilot Study on Low-Dose Immune Tolerance Induction (ITI) Therapy in Severe Hemophilia A Children with High-Titer Inhibitors
-
Abstract Number: PB2034
Pituitary Hormones Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH) and Prolactin (PRL) Modulate Endothelial Colony Forming Cells Angiogenic and Thrombotic Properties
-
Abstract Number: OC 11.3
Planned Induction versus Spontaneous Delivery among Women Using Prophylactic Anticoagulation Therapy
-
Abstract Number: PB0094
Plasma Calprotectin as a Novel Independent Predictor of Mortality in Acute Ischemic Stroke
-
Abstract Number: PB1780
Plasma Concentration of Activated Factor VII-antithrombin, But Not Tissue Factor Pathway Inhibitor and Factor VII Levels, Predicts Mortality in Subjects with Liver and Colon Cancer Undergoing Curative Surgical Intervention
-
Abstract Number: PB0102
Plasma Concentration of Apolipoprotein C-III is Associated with Ischemic Cerebrovascular Events in High-Risk Cardiovascular Patients Taking Anticoagulant Therapy with Warfarin
-
Abstract Number: PB0260
Plasma Contact Activation through T Cell-Derived Polyphosphate
-
Abstract Number: PB0013
Plasma Exosomes in Patients with ST‐Elevation Acute Myocardial Infarction (STEMI) and in Patients with Stable Coronary Artery Disease (CAD)
-
Abstract Number: PB0902
Plasma Factor VIII Activity Measured by Coagulation One-Stage and Chromogenic Assays in Patients with Hemophilia A Treated with Emicizumab
-
Abstract Number: PB0729
Plasma Fibrin Clots of Acute Pulmonary Embolism Patients Present Reduced Amounts of Coagulation Factor XIII and α2-antiplasmin Compared to Clots Generated after 3-Month Anticoagulation
-
Abstract Number: PB1744
Plasma Fibrinogen Interaction with Prion Peptide Mitigates Prion-Mediated Neuronal Cell Toxicity And Human Platelet Activation
-
Abstract Number: PB2063
Plasma from Patients under Direct Oral Anticoagulants (DOACs) Displays a Strong Resistance to Heparin Compared to Patients under Vitamin K Antagonists (VKA)
-
Abstract Number: PB2325
Plasma Levels of Complement Factor D and Future Risk of Incident Venous Thromboembolism
-
Abstract Number: PB0411
Plasma Levels of DNase I Activity and Circulating-free DNA Are Associated to an Increased Risk of Venous Thromboembolism
-
Abstract Number: PB0372
Plasma Levels of Platelet-derived Microvesicles Are Associated with Future Risk of Venous Thromboembolism
-
Abstract Number: PB2139
Plasma Levels of Procoagulant and Anticoagulant Factors in Patients with Acute Cancer-associated Thrombosis
-
Abstract Number: PB0436
Plasma Levels of von Willebrand Factor and Future Risk of Incident Venous Thromboembolism
-
Abstract Number: PB0370
Plasma Platelets Microparticles as a Biomarker of Thrombotic Event in Thrombotic Thrombocytopenic Purpura Patients
-
Abstract Number: OC 10.5
Plasma Protein Disulfide Isomerase Levels Predict Thrombosis in Myeloproliferative Neoplasms: A Prospective Cohort Study
-
Abstract Number: PB0416
Plasma Tissue Factor Pathway Inhibitor (TFPI) in Pediatric End Stage Liver Disease
-
Abstract Number: PB1868
PLASMIC Score Predicts Outcome of Transplanted Patients with Severe Thrombotic Thrombocytopenic Purpura
-
Abstract Number: PB1684
Platelet Activation and Aggregation Induced by NS1 Dengue Protein
-
Abstract Number: PB1813
Platelet Activation in Community-acquired Pneumonia Remains Increased Until 30 Days Later
-
Abstract Number: PB0843
Platelet Activation in Patients with Severe Haemophilia A
-
Abstract Number: PB/CO12
Platelet Activation is Associated with Thrombosis or Death in Patients with COVID-19
-
Abstract Number: PB1486
Platelet Activation Markers and Impaired Procoagulant Response in Pediatric Patients with Inherited Platelet Function Disorders
-
Abstract Number: PB0403
Platelet Activation via GPVI Initiates FXII- and TF-independent Thrombin Generation
-
Abstract Number: PB1665
Platelet Ageing Is Associated with Cytoskeletal Degradation and a Reduction in Cytoskeletal Dynamics
-
Abstract Number: PB1633
Platelet Aggregation is Suppressed in the Quinonoid Dihydropteridine Reductase Knockout Mice
-
Abstract Number: PB0558
Platelet Aggregation Testing by Light Transmission Aggregometry with Drug Specific Agonists in Patients on Mono and Dual Antiplatelet Therapy
-
Abstract Number: PB1711
Platelet Alpha-granule Secretion in Total Hip Replacement
-
Abstract Number: PB0134
Platelet Analysis of Diet-Induced Obesity Rat Model: Elucidating Platelet Dysfunction in Obesity
-
Abstract Number: PB1823
Platelet and Extracellular Vesicle Mediated Inflammasome Activation Impairs Embryonic Survival by Reducing Placental Thrombomodulin Expression
-
Abstract Number: PB1348
Platelet Count Variation in a Cohort of Patients with Chronic HCV-Related Liver Disease Treated with Direct-Acting Antivirals
-
Abstract Number: PB1846
Platelet Depletion Limits the Severity But Does Not Prevent the Occurrence of Experimental Transfusion-related Acute Lung Injury
-
Abstract Number: OC 13.5
Platelet Desialylation Affects Bleeding Tendency in Immune Thrombocytopenic Patients
-
Abstract Number: PB1471
Platelet Dysfunction and Coagulation Activation in Intracerebral Hemorrhage
-
Abstract Number: PB1427
Platelet Flow Cytometry in the Diagnosis of Heparin-induced Thrombocytopenia
-
Abstract Number: PB1712
Platelet Force-Producing Subpopulations Predicted by a Stochastic Model
-
Abstract Number: PB1797
Platelet Function and Coagulation Abnormalities in Polycythemia Vera Patients: Effects of Low-Dose Aspirin
-
Abstract Number: PB1384
Platelet Function Assay PFA-200 for Monitoring of Antiplatelet Drug Effect
-
Abstract Number: PB1793
Platelet Function in Primary Myelofibrosis
-
Abstract Number: PB1657
Platelet Functions Defects in Calreticulin and JAK2V617F MPN Patients
-
Abstract Number: PB0070
Platelet Glycoprotein IIIa Leu 33 Pro Polymorphism and Susceptibility to ST-segmented and Non-ST-segmented Myocardial Infraction
-
Abstract Number: PB1693
Platelet Interactions with von Willebrand Factor under Dynamic Shear Stress
-
Abstract Number: PB2026
Platelet miRNoma and Variability in the Responsiveness to Low-dose Aspirin in Patients with Type 2 Diabetes mellitus
-
Abstract Number: PB1685
Platelet PN-1 Regulates Clot Structure and Retraction
-
Abstract Number: PB0435
Platelet Procoagulant Membrane Dynamics in Cardiac Surgery with Cardiopulmonary Bypass: Outcomes of a Pilot Study
-
Abstract Number: PB1695
Platelet Procoagulant Potential Is Reduced in Platelet Concentrates ex vivo But Appears to Be Restored in vivo Following Transfusion
-
Abstract Number: PB1723
Platelet Proteomics to Understand the Pathophysiology of Immune Thrombocytopenia: Studies in Mouse Models
-
Abstract Number: PB1472
Platelet Purinergic Signaling Regulates Pulmonary Thrombosis in Sickle Cell Disease
-
Abstract Number: PB1511
Platelet Reactivity, Independed of Platelet Count, Is Associated with Bleeding Severity in Patients with Gaucher Disease
-
Abstract Number: PB1325
Platelet Surface GPIbα, Platelet Surface Activated GPIIb-IIIa and Platelet Surface P-Selectin in Veno-Arterial Extracorporeal Membrane Oxygenation Patients
-
Abstract Number: PB1837
Platelet β1 and β3 Integrins Cooperate to Stop Cutaneous and Cerebral Bleeding under Inflammatory Conditions in Mice
-
Abstract Number: PB0460
Platelet-Associated Tissue Factor Predicts 5-Years Mortality in Coronary Artery Disease Patients
-
Abstract Number: PB1668
Platelet-Derived Extracellular Vesicles Actively Process Proteins and Present Antigen via MHC Class I
-
Abstract Number: PB1802
Platelet-derived Microparticles Regulate Migration, But Do Not Influence Proliferation of Breast Cancer Cells
-
Abstract Number: PB1107
Platelet-targeted Hyperactive Factor IX (FIX) Gene Therapy for Hemophilia B Mice with Pre-existing Anti-FIX Immunity
-
Abstract Number: OC 08.4
Platelet-targeted Magnetic Nanoparticles Enhance the Efficacy of Thrombolysis through Induction of Magnetic Hyperthermia
-
Abstract Number: PB1662
Platelets and Aortic Valve Calcification: Insights from a Rabbit Model and from Patients with Severe Aortic Stenosis
-
Abstract Number: PB1833
Platelets Are Active Players as Inflammatory Cells in Nonalcoholic Fatty Liver Disease
-
Abstract Number: PB1728
Platelets as Immune Cells: Lateral Mobility Dynamics of FcγRIIA on Human Platelets is Directly Linked to Integrity of Platelet Cytoskeleton
-
Abstract Number: PB1828
Platelets Express a Stable and Functional Proteasome System and All Components of the Antigen Processing and Presentation Pathway (APP) Machinery
-
Abstract Number: OC 06.5
Platelets Expressing FcγRIIA/CD32A Determine the Severity of Immunological Transfusion-Related Acute Lung Injury in Mice
-
Abstract Number: PB1634
Platelets form Fibrillar Adhesions: Implications for Force-Regulated Thrombus Remodeling
-
Abstract Number: PB1448
Platelets Function and Cytoskeletal Organization in a Patient with a Novel Variant in ACTB Causing Macrothrombocytopenia
-
Abstract Number: PB1838
Platelets in Resolution of Liver Inflammation and Tissue Regeneration
-
Abstract Number: PB1849
Platelets Induce Rapid Subset and Phenotypic Switching in Monocytes in Whole Blood
-
Abstract Number: PB1654
Platelets May Be Involved in the Regulation of ITP Autoimmunity
-
Abstract Number: PB0346
Pleiotropic Effects of PCSK9-inhibition on Hemostasis: Anti-PCSK9 Reduce FVIII Levels by Enhancing LRP1 Expression
-
Abstract Number: PB0192
Point-of-Care and Storage-Stable, Single-Use 8-Channel Microfluidic Chip for Rapid Testing of DOACs and DOAC Reversal Agents under Whole Blood Flow
-
Abstract Number: PB0677
Point-of-Care Method in Determining the Activated Partial Thromboplastin Time
-
Abstract Number: PB2385
Point-of-Care Monitoring of Unfractionated Heparin Treatment in the Intensive Care Unit: Preliminary Results of a Comparative Study with Laboratory-based APTT and Anti-Xa Activity
-
Abstract Number: PB1279
Polygenic Risk Score-Analysis of Thromboembolism in Patients with Acute Lymphoblastic Leukemia
-
Abstract Number: PB0743
Polyphosphate Nanoparticles Are More Potent Stabilizers of Fibrin than Linear Polyphosphates and Histones Enhance their Effect
-
Abstract Number: PB1352
Pooled Safety Analysis of Avatrombopag (AVA) from Clinical Trials
-
Abstract Number: PB0118
Poorly Compressible Lower Extremity Arteries Are Associated with Venous Thromboembolism
-
Abstract Number: PB0949
Population Pharmacokinetic (PK) Analysis of BIVV001 (Rfviiifc-VWF-XTEN), a New Class of Factor VIII (FVIII) Replacement
-
Abstract Number: PB1065
Population Pharmacokinetic Simulation Analysis for Extended Dosing Regimens of Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Adult and Pediatric Patients with Hemophilia B
-
Abstract Number: PB1541
Population Pharmacokinetics and Pharmacodynamics of Recombinant von Willebrand Factor
-
Abstract Number: PB2256
Portal Vein Thrombosis Revealing Paroxysmal Nocturnal Hemoglobinuria
-
Abstract Number: PB2225
Positive Thrombophilia Study in the Context of Starting Hormonal Treatment in the Gender Dysphory: Experience in a Single Center
-
Abstract Number: PB0661
Possibilities of Thromboelastography in Patients with Severe Burns
-
Abstract Number: PB1367
Possible Impact of Polymorphism of GSTM1 and GSTT1 Genes on Bleeding Tendency in Immune Thrombocytopenia
-
Abstract Number: PB2349
Post-Discharge Hospital-Associated Venous Thromboembolism
-
Abstract Number: PB2210
Post-Thrombotic Syndrome in Patients with Venous Thromboembolism Treated with Dabigatran or Warfarin – a Long-Term Cross-Sectional Follow-up of RE-COVER Study Patients
-
Abstract Number: PB0020
Postoperative Dual Antiplatelet Therapy Is Influenced by Platelet Regeneration
-
Abstract Number: PB0297
Postoperative Heparin Monitoring by Anti-Xa Is More Accurate Than by aPTT After Pulmonary Endarterectomy – Role of Increased Systemic and Endothelial Production of Factor VIII
-
Abstract Number: PB0777
Postpartum Acquired Hemophilia A Persists as a Diagnostic Challenge
-
Abstract Number: PB1394
Potent platelet inhibition results in improved long-term clinical outcome independent from clinical variables
-
Abstract Number: PB0337
Potential Role for Regulatory B-cells in the Control of Immune Tolerance to Factor VIII Treatment in Haemophilia A: Evaluation of Involvement of Regulatory Cell Types and Markers in Immune Tolerance Induction (ITI) in Haemophilia A
-
Abstract Number: PB0402
Praxbind for Reversal of Dabigatran: Experience in a Tertiary Hospital
-
Abstract Number: PB0561
Pre – Analytical Variables in Haemostasis: Results of the UK National External Quality Assessment Scheme for Blood Coagulation Haemolysis Supplementary Exercise
-
Abstract Number: PB2401
Pre-Treatment with Heparinoids Does Not Impact Clinical Outcome of Apixaban and Rivaroxaban in Patients Treated for Venous Thromboembolism
-
Abstract Number: PB0443
Preanalytical Considerations for Evaluation of NETosis Biomarkers
-
Abstract Number: OC 06.2
Preclinical in Vivo Characterization of a First-In-Class, Fully Humanized Antibody Targeting Alternatively Spliced Tissue Factor
-
Abstract Number: PB0187
Preclinical Pharmacology of BAY 2433334, a Small Molecule Inhibitor of Coagulation Factor XIa
-
Abstract Number: PB2480
Predicting Factors for Pulmonary Embolism Response Team (PERT) Activation in a General Pulmonary Embolism Population
-
Abstract Number: PB2433
Predicting Recurrence and Bleeding in Patients with Venous Thromboembolism: A Systematic Review and Critical Appraisal of Prediction Models
-
Abstract Number: PB0925
Prediction Markers for Development of Persistent Inhibitors in Previously Untreated Patients with Severe Hemophilia A
-
Abstract Number: PB1739
Prediction of Dynamic Structural Changes in the Complex of Platelet Glycoprotein (GP) Ibα Bound with von Willebrand Factor in the Absence and Presence of Coagulation Factor XI using Molecular Dynamics Simulations
-
Abstract Number: PB0828
Prediction of the Response to FVIII Treatment in Haemophilia A
-
Abstract Number: PB2271
Predictive Accuracy of Computed Tomography Pulmonary Perfusion Imaging for Adverse Outcome in Patients with Acute Pulmonary Embolism
-
Abstract Number: PB1251
Predictive Factors for Disseminated Intravascular Coagulation in Childhood Acute Lymphoblastic Leukemia
-
Abstract Number: PB1326
Predictive Factors of Chronicity in Adult Idiopathic Thrombocytopenic Purpura
-
Abstract Number: PB0357
Predictive Role of Natural Anticoagulants in Prognosis of Chronic Liver Disease in Pediatric Age Group
-
Abstract Number: PB2093
Predictive Value of CBC Indices in Determining Risk of Atrial Fibrillation After Pulmonary Embolism
-
Abstract Number: PB2053
Predictors of Left Atrial Thrombus before Catheter Ablation or Cardioversion in Patients with Non-Valvular Atrial Fibrillation
-
Abstract Number: PB0298
Predictors of Residual Preprocedural DOAC Levels
-
Abstract Number: PB2377
Predictors of Venous Thromboembolic Events (VTE) in Patients with Testicular Cancer
-
Abstract Number: PB1869
Pregnancy and Non-Pregnancy Related Acquired Thrombotic Thrombocytopenic Purpura in Women of Reproductive Age: Clinical Course and Outcomes
-
Abstract Number: PB2554
Pregnancy Associated Bleeding in Women with Inherited Bleeding Disorders
-
Abstract Number: PB2508
Pregnancy Complications among Filipino Women
-
Abstract Number: PB2531
Pregnancy Complications and Outcomes in Women with Moderate and Severe von Willebrand Disease (VWD)
-
Abstract Number: PB2538
Pregnancy Outcomes in Women with Budd Chiari Syndrome or Portal Hypertension
-
Abstract Number: PB2310
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
-
Abstract Number: PB2396
Preliminary Investigation of Venous Thromboembolism Risk Assessment and Prophylaxis for Medical In-patients: A Multicenter Study in Nigeria
-
Abstract Number: PB2091
Preliminary Results from EGINA Registry: A New Model in the Management of Anticoagulation with DOACs in Southern Italy
-
Abstract Number: PB0287
Presentation of Three Patients Treated with Dabigatran that Strongly Confirm the Importance of Quantitative Measurement of Dabigatran Concentration in Selected Clinical Situations: Case Reports
-
Abstract Number: PB1101
Prevalence and Affinity/Avidity Assessment of Pre-Existing Neutralizing Antibodies (NABs) against Adeno-Associated Virus (AAV) Vector Serotypes 2, 5 and 8 Analyzed in the Serum of 300 Healthy Donors
-
Abstract Number: PB1381
Prevalence and Clinical Significance of Abnormal T-cell Large Granular Lymphocytes in Patients with Immune Thrombocytopenia
-
Abstract Number: PB1564
Prevalence and Diagnostic Rate of von Willebrand Disease in an Argentine Medical Care Program
-
Abstract Number: PB0345
Prevalence and Incidence of Non-neutralizing Antibodies in Congenital Hemophilia – A Systematic Review and Meta-analysis
-
Abstract Number: PB1263
Prevalence and Management Approach to the Newborn with Classical and Late Vitamin K Deficiency Bleeding (VKDB) in LMIC
-
Abstract Number: PB2549
Prevalence and Management of Post Partum Hemorrhage in Latin America: An Overview of Systematic Reviews
-
Abstract Number: PB0697
Prevalence and Pattern of Pseudo-thrombocytopenia in a Nigerian Tertiary Hospital
-
Abstract Number: PB2369
Prevalence and Predictors of Thromboembolic Events in Patients with Gastric Cancer
-
Abstract Number: PB2375
Prevalence and Predictors of Venous Thromboembolic Events (VTE) in Patients Undergoing Salvage Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Lymphomas
-
Abstract Number: PB1928
Prevalence of “Cofactor Effect” on Lupus Anticoagulant Mixing Studies: Patients and Laboratory Characteristics
-
Abstract Number: PB2334
Prevalence of Bilateral DVT in Ghanaian Patients
-
Abstract Number: PB1989
Prevalence of Disseminated Microvascular Thrombosis, Unresolved Infection, and Lymphoid Depletion in Autopsies of Pediatric Sepsis-Induced Disseminated Intravascular Coagulation (DIC)
-
Abstract Number: PB2343
Prevalence of Pulmonary Embolism in Patients Accessing the Emergency Department, Reported by Country of Study: A Systematic Review and Meta-analysis
-
Abstract Number: PB/CO10
Prevalence of Pulmonary Embolism in Patients at the Time of Hospital Admission for COVID-19
-
Abstract Number: PB1282
Prevalence, Characteristics and Risk Factors of Peripherally Inserted Central Catheter-Related Venous Thromboembolism in a Pediatric Intensive Care Unit: A Cross-Sectional Retrospective Study
-
Abstract Number: PB2380
Preventing Maternal Death and Morbidity from Venous Thromboembolism (VTE): Results from a VTE Risk Score Trial during Hospitalization
-
Abstract Number: PB2383
Prevention of Catheter Complications in Patients with Cystic Fibrosis: Enoxaparin vs. a Direct Oral Anticoagulant
-
Abstract Number: PB2215
Prevention of Post-thrombotic Syndrome with Elastic Compressive Stockings
-
Abstract Number: PB0318
Prevention of Thromboembolism Complications in Preoperative Patients
-
Abstract Number: PB2354
Prevention of Thrombogenesis in the Development of Metabolic Syndrome
-
Abstract Number: PB2227
Primary Aortic Thrombus with Multiple Visceral Embolisation: A Presenting Manifestation of Chronic Myelomonocytic Leukemia
-
Abstract Number: PB0940
Primary Prophylaxis Assessment in Patients with Severe Haemophilia A without Inhibitors Based on Genetic Load and Thrombin Generation Test
-
Abstract Number: PB1991
Pro‑Inflammatory Cytokines, Tissue Factor Gene Polymorphism (A603G, C1322T, C1812T, G1442C) and Tissue Factor Expression in Patient with Erysipelas
-
Abstract Number: PB0222
Probing Interaction of TOS with ATIII Using MD Simulation and Biophysical Studies; Its Effect on Clot Formation and fXa Inhibition
-
Abstract Number: PB0377
Procoagulant Microparticles Improve Hemostasis in Mice with Haemophilia A
-
Abstract Number: PB0754
Production of Nanobodies Targeting Plasminogen and Plasmin
-
Abstract Number: PB0305
Profile of Effect of Sugammadex on Coagulation and Fibrinolysis
-
Abstract Number: PB2094
Profile of Patients Using Oral Anticoagulants in Primary Care: ‘Anticoagula Divinópolis” Project
-
Abstract Number: PB1704
Profiling of COX-dependent Eicosanoids Produced by Blood Cells and the Vasculature
-
Abstract Number: PB0466
Profiling of Inflammatory Biomarkers and Coagulation Factors in End-stage Renal Disease
-
Abstract Number: PB1858
Prognostic Value of A Disintegrin and Metalloprotease with Thrombospondin Motif 13 in Patients with Severe Sepsis and Septic Shock
-
Abstract Number: PB1822
Prognostic Value of Platelet-Derived Parameters in Septic Patients: A Prospective Study
-
Abstract Number: PB0892
Promising Prospective Data on the Effect of Ankle Joint Distraction in Hemophilic Arthropathy
-
Abstract Number: PB2006
Promising Therapeutic Effects of a Novel RNA Aptamer, Apta-1, in a Severe Systemic Inflammation Model on Non-human Primates
-
Abstract Number: PB0899
Prophylactic Factor VIII Consumption and Clinical Outcomes in Italian Hemophilia A Patients who Switched to Extended Dosing Intervals with Long-Acting rVIII-SingleChain: A Retrospective Patient Chart Review
-
Abstract Number: PB0791
Prophylactic Potential of Standard and Modified Emicizumab Prophylaxis in 2 Patients with Acquired Hemophilia: A Case Report
-
Abstract Number: PB1038
Prophylactic Treatment with Low or Medium Dose Factor VIII for Children with Severe Hemophilia A in China: Evaluation of Joint Progression by Conventional Ultrasound and Hemophilia Joint Health Score
-
Abstract Number: PB0160
Prophylaxis in Adult Population. Experience and Results in a 5-Year Follow-up Cohort
-
Abstract Number: PB0871
Prophylaxis Outcome in Patients with Severe Hemophilia in Southern Iran: Near Five-Year Experience from a Single-Center Study
-
Abstract Number: PB1029
Prophylaxis with Emicizumab in Children and Adults with Hemophilia A and Inhibitors: Real-World Data of 17 Patients from 4 Portuguese Hemophilia Treatment Centers
-
Abstract Number: PB1566
Prophylaxis with Recombinant von Willebrand Factor in a Case of Concomitant von Willebrand’s Disease and CREST Syndrome
-
Abstract Number: PB0886
Prophylaxis with Turoctocog Alfa Pegol (N8-GP) Maintains Improvements in Health-Related Quality of Life (HRQoL) and Treatment Satisfaction (TS) over ≥4.5 Years in Patients with Haemophilia A (HA)
-
Abstract Number: PB1008
Prospective Comparative Analysis of Joint Structure and Function in Chinese Children with Severe Hemophilia A under Different Doses Factor Ⅷ
-
Abstract Number: PB1412
Prospective Comparison of Two Specific IgG Immunoassays (HemosIL® AcuStar HIT IgG and HAT 45-G®) for the Biological Diagnosis of Heparin-Induced Thrombocytopenia: A Bayesian Approach
-
Abstract Number: PB2276
Prospective Study of a Screening Protocol for Venous Thromboembolic Complications in Patients Operated on for Pelvic Ring Fractures
-
Abstract Number: PB0293
Prospective Study of Haemostatic Activation Markers and Correlation with Bleeding and Thrombotic Complications in Patients Receiving Veno-Venous Extra-Corporeal Membrane Oxygenation (VV-ECMO) – HAE Study
-
Abstract Number: PB0932
Prospective, Non-Interventional Study to Assess the Burden in Adolescents and Adults with Haemophilia A (HA) without Inhibitors and their Caregivers in Spain – Hemolife Study
-
Abstract Number: PB0338
Protease Domain Determinants of the Distribution, Clearance and in vivo Activity of Human Factor IX(a) in Hemophilic Mice
-
Abstract Number: PB0078
Proteases from Pathogenic and Non-pathogenic Bacteria Activate Prothrombin (ProT) in Human Plasma: Implications in Thrombotic Diseases
-
Abstract Number: PB0156
Protein C Activity and Fibrinogen Levels in Nigerians Receiving Renal Replacement Therapy for Chronic Kidney Disease
-
Abstract Number: PB0496
Protein Expression Profiling Suggests Relevance of Non-Canonical Pathways in Isolated Pulmonary Embolism
-
Abstract Number: PB0195
Protein S Deficiency, Inflammation and Sickle Cell Anemia
-
Abstract Number: PB0851
Proteomic Profile of Blood Outgrowth Endothelial Cells (BOEC) from a Severe HA Patient with the Reintroduction of FVIII
-
Abstract Number: PB1584
Prothrombotic Gain-of-Function Variants of von Willebrand Factor
-
Abstract Number: PB1228
Psychosocial Burden of Hemophilia in a Canadian Cohort
-
Abstract Number: PB0294
PTT a Surrogate for Quantification of Factor VIII Inhibitor
-
Abstract Number: PB2198
Pulmonary Embolism and Thrombophilia Gene Mutations: Georgian Population Study
-
Abstract Number: PB2149
Pulmonary Embolism as a Presenting Manifestation of Cerebral Glial Tumor
-
Abstract Number: PB1295
Pulmonary Embolism in Pediatric Age: Retrospective Analysis of 10 Year Period in a Tertiary Hospital
-
Abstract Number: PB1298
Pulmonary Embolism in Pediatric Patients: A Ten-year Experience from a Tertiary Center in Brazil
-
Abstract Number: PB0085
Pulmonary Thromboembolism in General Practice
ISTH 2020 Congress
July 12-14, 2020. Virtual Congress.